5. Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol. 2006 Nov-Dec;27(10):2179-2190;
6. Bartynski WS, Zeigler Z, Spearman MP, Lin L, Shadduck RK, Lister J. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol. 2001 Nov-Dec;22(10):1901-1914;
9. Cooney MJ, Bradley WG, Symko SC, Patel ST, Groncy PK. Hypertensive encephalopathy: Complication in children treated for myeloproliferative disorders- Report of three cases. Radiology. 2000 3;214(3):711-716;
10. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol. 1998 11;179(5):1359-1375;
11. Domínguez-Fuentes B, Garcia-Gil D, Romero-Palacios A, Sanchez-Crespo JM, Garcia-Arjona R, Navarro-Navarro J. [Posterior reversible leukoencephalopathy in a patient with postpartum eclampsia]. Med Intensiva. 2008 10;32(7):361-363; Spanish.
12. Edvinsson L, Owman C, Sjoberg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res. 1976 10;115(3):377-393;
13. Eichler FS, Wang P, Wityk RJ, Beauchamp NJ Jr, Barker PB. Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol. 2002 5;23(5):833-837;
14. Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med. 2006 3;354(9):980-982; discussion 980-2.
16. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 2;334(8):494-500;
17. Ito Y, Arahata Y, Goto Y, Hirayama M, Nagamutsu M, Yasuda T, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol. 1998 3;19(3):415-417;
18. Kinoshita T, Moritani T, Shrier DA, Hiwatashi A, Wang HZ, Numaguchi Y, et al. Diffusion-weighted MR imaging of posterior reversible leukoencephalopathy syndrome: A pictorial essay. Clin Imaging. 2003 Sep-Oct;27(5):307-315;
20. Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol. 2001 5;24(5):361-364;
21. Lassila M, Santisteban J, Finckenberg P, Salmenpera P, Riutta A, Moilanen E, et al. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. J Physiol Pharmacol. 2001 3;52(1):21-38;
22. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008 2;65(2):205-210;
23. Lin JT, Wang SJ, Fuh JL, Hsiao LT, Lirng JF, Chen PM. Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. AJNR Am J Neuroradiol. 2003 1;24(1):102-104;
24. Min L, Zwerling J, Ocava LC, Chen IH, Putterman C. Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum. 2006 6;35(6):388-395;
27. Pula JH, Eggenberger E. Posterior reversible encephalopathy syndrome. Curr Opin Ophthalmol. 2008 11;19(6):479-484;
28. Schaefer PW, Gonzalez RG, Hunter G, Wang B, Koroshetz WJ, Schwamm LH. Diagnostic value of apparent diffusion coefficient hyperintensity in selected patients with acute neurologic deficits. J Neuroimaging. 2001 10;11(4):369-380;
29. Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol. 1995 9;165(3):627-631;
30. Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, Garada B, et al. Hypertensive encephalopathy: Findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol. 1992 8;159(2):379-383;
33. Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke. 1988 3;19(3):326-329;
35. Weingarten K, Barbut D, Filippi C, Zimmerman RD. Acute hypertensive encephalopathy: Findings on spin-echo and gradient-echo MR imaging. AJR Am J Roentgenol. 1994 3;162(3):665-670;